WebOct 3, 2024 · William "Trey" Martin, III ... OfficerHull to Serve as Executive Chairman of the Board of Directors SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. ... WebSAN DIEGO, Calif.; – December 1, 2024—Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech …
Maravai’s Competitors, Revenue, Number of Employees, Funding ...
WebMaravai’s primary competitors include Enzo Life Sciences, BioGenes, Rockland and 5 more. ... Maravai is a California-based holding company that owns and operates drug therapies and novel vaccine development businesses across the United States... Read more. CEO. Trey Martin III. CEO Approval Rating. 87/100. Weigh In. 2014. San Diego California. WebTrey Martin has more than 25 years of executive leadership experience in life sciences operations, engineering, sales, and marketing. Prior to joining Maravai, he was most … matthew minson writer
Maravai Lifesciences temporarily reinstates Carl Hull as CEO
WebOct 6, 2024 · Maravai LifeSciences saw revenue jump from $143 million in 2024 to $799 million in 2024. On the one hand, the company generates revenue from more than just mRNA vaccines and mRNA clinical trials ... WebDec 1, 2024 · Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in ... WebTrey Martin has more than 25 years of executive leadership experience in life sciences operations, engineering, sales, and marketing. Prior to joining Maravai, he was most … matthew minson md